Correction: The mutational landscape of ocular marginal zone lymphoma identifies frequent alterations in TNFAIP3 followed by mutations in TBL1XR1 and CREBBP.

Jung, Hyunchul; Yoo, Hae Yong; Lee, Seung Ho; Shin, Sohyun; Kim, Sang Cheol; Lee, Sejoon; Joung, Je-Gun; Nam, Jae-Yong; Ryu, Daeun; Yun, Jae Won; Choi, Jung Kyoon; Ghosh, Ambarnil; Kim, Kyeong Kyu; Kim, Seok Jin; Kim, Won Seog; Park, Woong-Yang; Ko, Young Hyeh

Correction: The mutational landscape of ocular marginal zone lymphoma identifies frequent alterations in TNFAIP3 followed by mutations in TBL1XR1 and CREBBP.

Jung, Hyunchul; Yoo, Hae Yong; Lee, Seung Ho; Shin, Sohyun; Kim, Sang Cheol; Lee, Sejoon; Joung, Je-Gun; Nam, Jae-Yong; Ryu, Daeun; Yun, Jae Won; Choi, Jung Kyoon; Ghosh, Ambarnil; Kim, Kyeong Kyu; Kim, Seok Jin; Kim, Won Seog; Park, Woong-Yang; Ko, Young Hyeh.

Afiliación

Jung H; Department of Bio and Brain Engineering, Korea Advanced Institute of Science and Technology (KAIST), Daejeon, Republic of Korea.
Yoo HY; Samsung Genome Institute, Research Institute for Future Medicine, Samsung Medical Center, Seoul, Korea.
Lee SH; Department of Health Sciences and Technology, Samsung Advanced Institute for Health Sciences and Technology, Sungkyunkwan University, Seoul, Korea.
Shin S; Department of Health Sciences and Technology, Samsung Advanced Institute for Health Sciences and Technology, Sungkyunkwan University, Seoul, Korea.
Kim SC; Department of Pathology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Lee S; Samsung Genome Institute, Research Institute for Future Medicine, Samsung Medical Center, Seoul, Korea.
Joung JG; Samsung Genome Institute, Research Institute for Future Medicine, Samsung Medical Center, Seoul, Korea.
Nam JY; Samsung Genome Institute, Research Institute for Future Medicine, Samsung Medical Center, Seoul, Korea.
Ryu D; Department of Health Sciences and Technology, Samsung Advanced Institute for Health Sciences and Technology, Sungkyunkwan University, Seoul, Korea.
Yun JW; Samsung Genome Institute, Research Institute for Future Medicine, Samsung Medical Center, Seoul, Korea.
Choi JK; Department of Health Sciences and Technology, Samsung Advanced Institute for Health Sciences and Technology, Sungkyunkwan University, Seoul, Korea.
Ghosh A; Samsung Genome Institute, Research Institute for Future Medicine, Samsung Medical Center, Seoul, Korea.
Kim KK; Samsung Genome Institute, Research Institute for Future Medicine, Samsung Medical Center, Seoul, Korea.
Kim SJ; Department of Molecular Cell Biology, Samsung Biomedical Research Institute, Sungkyunkwan University School of Medicine, Suwon, Republic of Korea.
Kim WS; Department of Bio and Brain Engineering, Korea Advanced Institute of Science and Technology (KAIST), Daejeon, Republic of Korea.
Park WY; Department of Molecular Cell Biology, Samsung Biomedical Research Institute, Sungkyunkwan University School of Medicine, Suwon, Republic of Korea.
Ko YH; Department of Molecular Cell Biology, Samsung Biomedical Research Institute, Sungkyunkwan University School of Medicine, Suwon, Republic of Korea.

Oncotarget ; 9(67): 32882, 2018 08 28.

Article en En | MEDLINE | ID: mdl-30214692

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Oncotarget Año: 2018 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Oncotarget Año: 2018 Tipo del documento: Article